Release Date: 16/01/18 09:10 Summary: Increased expansion, strategic placement and financing Price Sensitive: Yes Download Document 443.87KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%